Skip to main content
. Author manuscript; available in PMC: 2013 Sep 23.
Published in final edited form as: Am J Transplant. 2006 Apr;6(4):687–696. doi: 10.1111/j.1600-6143.2006.01235.x

Table 3.

Suboptimal anti-CD154-based immunosuppression

Monkey no.
(IEQ/kg)
Treatment Survival
(days)
8 (11 500) RPM (low),
anti-CD154 (low)1
24
9 (12 500) RPM and anti-CD154 65
10 (14 300 + 8200) 160
11 (15 700) RPM, DST and
 anti-CD1542 (DST
 and RPM on day 03)
14
12 (20 800) RPM, DST and
 anti-CD154 (DST on
 day −17)
96
13 (16 100) RPM, DST and
 anti-CD154 (DST on
 day −2)
100
1

Anti-CD154 treatment started at the time of transplantation.

2

When used with DST, the first dose of anti-CD154 was given at the time of the lymphocyte infusion and then continued at the time of transplantation.

3

Rapamycin was started on day 0, along with DST and anti-CD154. Rapamycin started on day −2 for all other monkeys.